Singapore provisionally approves Novavax’s COVID-19 vaccine

A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” label and a medical syringe in front of the Novavax logo shown in this illustration taken, October 30, 2020. REUTERS / Dado Ruvic

SINGAPORE, February 14 (Reuters) – Singapore Health Sciences Authority (HSA) said Monday it has granted a temporary permit to Novavax’s (NVAX.O) Vaccine against covid-19.

The first batch of Nuvaxovid vaccine is expected to arrive in Singapore over the next few months, the HSA said.

Reporting by Aradhana Aravindan in Singapore Editing by Ed Davies

Our standards: Thomson Reuters trust principles.